Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

TS03 Inc Trust Units TSTIF



GREY:TSTIF - Post by User

Post by Drrwongon May 19, 2018 7:58pm
310 Views
Post# 28057280

LinkedIn Due Diligence

LinkedIn Due DiligenceJust came across this today on my routine LinkedIn tour :-)

https://www.linkedin.com/feed/update/urn:li:activity:6402931242815365120/

This is a post by "Dalebout Donald", who is a Getinge US account manager.  A couple of key takeaways:

1)  We are seeing more Getinge activity surrounding the VP4

2)  In the comments section, please a note a post by "Penny Sabrosky", who is an independent sterilization expert.  Her quote: "I know several happy customers with this (VP4) sterilizer.  Every speaker I have heard this past month nationaly and locally is predicting low temperature sterilization will be the future for flexible scopes.  Start budgeting today is my suggestion!"

And we all know which (and ONLY) low temp sterilizer that is FDA approved to sterilize flexible scopes, including the most problematic duodenoscopes

With the duodensocope claim now approved, and the cost savings data finalized by real-life account experience, I continue to believe we are now ready for takeoff...hang on for the ride!!

For those who disagree, please give me a good reason why any 300+ beds hospitals won't need the capability (i.e.: at least one VP4)  to sterilize either all duodenoscopes, or any scopes (not just ERCP) that had been used on a known patient with multi-drug resistant infection, or risk a hefty legal case if something goes wrong...

Given all these positive customer testimonials (direct or indirect), I am sure once these hospitals have tried one VP4, they will fall in love and order more.  Just ask the two customers at the analyst day who ordered 12 more themselves...
<< Previous
Bullboard Posts
Next >>